Overview

The Orange County Symposium for Cardiovascular Disease Prevention is designed to fill knowledge gaps in the fast-evolving field of preventive cardiology. Primary care providers, cardiologists, endocrinologists, lifestyle interventionists, and other specialists will be updated this year on: 1) How practices from hunter gatherer populations inform us about preventing heart disease 2) Role of the mammogram and breast arterial calcification in informing women of their cardiovascular risk 3) Importance of inflammation as a major cause of cardiovascular disease 4) Role of epigenetics in cardiovascular disease prevention 5) How polygenic risk scoring can inform precision cardiovascular care 6) Importance of social determinants of health in preventive cardiology 7) Nutraceuticals in cardiovascular disease prevention 8) Non-Alcoholic Fatty Liver Disease and CVD – What’s the Connection? 9) The new Cardio-Kidney-Metabolic Syndrome and its importance in cardiovascular disease 10) Lipoprotein(a) as the new frontier in cardiovascular prevention 11) GLP1-RA therapy in obesity management and the prevention of cardiovascular disease 12) Triglyceride Rich Lipoproteins and Why They are Important

Learning Objectives

At the conclusion of this activity, learners will be able to:

1. Discuss how practices from hunter gatherer populations inform us about atherosclerosis
2. Discuss the role of the mammogram and breast arterial calcification in informing women of their cardiovascular risk
3. Discussion evaluation of the vulnerable plaque and patient and implications for cardiovascular disease prevention
4. Discuss the importance of inflammation as a major cause of cardiovascular disease
5. Discuss the emerging epidemic of atrial fibrillation and strategies for its prevention and management
6. Discuss the role of epigenetics in cardiovascular disease prevention
7. Discuss how polygenic risk scoring can inform precision cardiovascular care
8. Discuss the role of maternal nutrition in cardiovascular disease prevention
9. Discuss the role of non-Alcoholic Fatty Liver Disease and CVD
10. Discuss the new Cardio-Kidney-Metabolic Syndrome and its importance in cardiovascular disease
11. Discuss the role of lipoprotein(a) in cardiovascular prevention
12. Discuss the role of GLP1-RA therapy in obesity management and the prevention of cardiovascular disease
13. Discuss the role of triglyceride rich lipoproteins and why they are important
14. Discuss the role of stress and how to manage it for the prevention of cardiovascular disease

Target Audience

Specialties - Cardiology, Endocrinology, General Internal Medicine & Primary Care, Medicine, Nephrology, Hypertension & Kidney Transplantation

Professions - Allied Health Professional, Medical Assistant, Medical Student, Non-Physician, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Registered Dietitian, Resident Physician

Accreditation

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours).

For more information please visit the official event page.